Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2017

Open Access 01-12-2017 | Research article

The analysis of relationship between selected sociodemografic factors and disorders of speech organs in Parkinson`s patients

Authors: Wioletta Pawlukowska, Karolina Skonieczna-Żydecka, Iwona Rotter, Krystyna Honczarenko, Przemysław Nowacki

Published in: BMC Neurology | Issue 1/2017

Login to get access

Abstract

Background

Evaluation of speech disorders in PD taking into account sociodemographic conditions is not frequent. This paper aims to establish correlations between articulation disorders in PD patients and factors such as the patients’ sex, age, education and residence.

Methods

The study included 92 patients with idiopathic PD diagnosed by means of multiple neurological examinations, biochemical tests, MRI and CT scanning carried out in accordance with the United Kingdom Parkinson’s Disease Society Brain Bank (UKPDSBB) criteria. A speech and language test involved the assessment of the mobility of the speech organs as well as the reflexes inside the oral cavity. Frenchay Dysarthria Assessment was applied for an objective evaluation of dysarthria.

Results

The study revealed the existence of significant relationship between the functionality of articulators in PD patients and their education and residence. Big city dwellers demonstrated lower incidence of disorders within speech organs, particularly those affecting mobility of the soft palate while eating. Disorders of moderate intensity were more frequently found in subjects living in villages. Subjects with a university education displayed better position of the lips at rest and better performance of both lips and the mandible while speaking.

Conclusions

Abnormal functioning of the articulatory organs was observed more frequently in PD patients residing in rural areas than in those inhabiting urban areas. As for education, our cohort university graduates displayed a better position of the lips at rest and better performance of the lips and jaw during speaking than those with secondary and vocational education.
Literature
1.
Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson’s disease. Lancet Neurol. 2006;5:75–86.CrossRefPubMed
2.
Petit H, Allain H, Vermersch P. Choroba Parkinsona. Warszawa: Tł. pod red. A. Friedmana Wyd. Med. Sanmedia; 1997.
3.
Skodda S, Grönheit W, Mancinelli N, Schlegel U. Progression of voice and speech impairment in the course of Parkinson’s disease: a longitudinal study. Parkinson Dis. 2013;2013:ID389195.
4.
Forrest K, Nygaard L, Pisoni DB, Siemers E. Effects of speaking rate on word recognition in Parkinson’s disease and normal aging. J Med Speech Lang Pathol. 1998;6:1–12.PubMedPubMedCentral
5.
Weismer G, Jeng J, Laures J, Kent RD, Kent JF. Acoustic and intelligibility characteristics of sentence production in neurogenic speech disorders. Folia Phoniat. 2001;53:1–18.CrossRef
6.
Walsh B, Smith A. Articulatory movements in adolescents: evidence of protracted development of speech motor control processes. J Speech Lang Hear Res. 2002;45:1119–33.CrossRefPubMed
7.
Dromey C. Spectral measures and perceptual ratings of hypokinetic dysarthria. J Med Speech Lang Pathol. 2003;11:85–94.
8.
Kleinow J, Smith A, Ramig L. Speech motor stability in IDP: effects of rate and loudness manipulations. J Speech Lang Hear Res. 2001;44:1041–51.CrossRefPubMed
9.
Smith ME, Ramig LO, Dromey C, Perez KS, Samandari R. Intensive voice treatment in Parkinson disease: laryngostroboscopic findings. J Voice. 1995;9(4):453–9.CrossRefPubMed
10.
11.
12.
Huber JE, Chandrasekaran B. Effects of increasing sound pressure level on lip and jaw movement parameters and consistency in young adults. J Speech Lang Hear Res. 2006;49:1368–79.CrossRefPubMedPubMedCentral
13.
Ramig LO, Sapir S, Fox C. Speech, voice, and swallowing disorders. [W]. In: Pahwa P, Lyons KE, Koller WC, editors. Therapy of Parkinson’s disease. Wyd. 3rd ed. New York: Marcel Dekker, Inc; 2004.
14.
Ho AK, Bradshaw JL, Iansek R, Alfredson R. Speech volume regulation in Parkinson’s disease: effects of implicit cues and explicit instructions. Neuropsychologia. 1999;37:1453–60.CrossRefPubMed
15.
Dias AE, Barbosa MT, Papaterra Limongi JC, Barbosa ER. Speech disorders did not correlate with age at onset of Parkinson’s disease. Arq Neuropsiquiatr. 2016;74(2):117–121.
16.
Dowding CH, Shenton CL, Salek SS. A review of the health-related quality oflife and economic impact of Parkinson’s disease. Drugs Aging. 2006;23:693–721.CrossRefPubMed
17.
Schoenberg BS, Osuntokun BO, Adeuja AO, Bademosi O, Nottidge V, Anderson DW, et al. Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies. Neurology. 1988;38:645–6.CrossRefPubMed
18.
Brown TP, Rumsby PC, Capleton CA. Pesticides and Parkinson’s disease—is there a link? Environ Health Perspect. 2006;114(2):156–64.CrossRefPubMed
19.
Wirdefeldt K, Adami H, Cole P, Trichopoulos D, Mandel J. Epidemiology of etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011;26:1–58.CrossRef
20.
21.
Ohtaki S, Ohtaki T, Fetters MD. Doctor-patient communication: a comparison of the USA and Japan. Fam Pract. 2003;20(3):276–82.CrossRefPubMed
22.
Skodda S, Visser W, Schlegel U. Vowel articulation in Parkinson’s disease. J Voice. 2011;25(4):467–72.CrossRefPubMed
23.
Skodda S, Grönheit W, Schlegel U. Impairment of vowel articulation as a possible marker of disease progression in Parkinson’s disease. PLoS One. 2012;7(2):32132.CrossRef
24.
Enderby P., Palmer R.: Frenchay Dysrthria assessment. English. San Diego: College Hill Press; 1983.
25.
26.
Shapiro SS, Wilk MB. An analysis of variance test for nomality (complete samples). Biometics. 1965;52:591–611.
27.
Mann HB, Whitney DR. On a test of whether one of two random variables is stohastically larger than the other. Ann Math Stat. 1947;18:50–60.CrossRef
28.
29.
Forrest K, Weismer G, Turner GS. Kinematic, acoustic, and perceptual analyses of connected speech produced by Parkinsonian and normal geriatric adults. J Acoust Soc Am. 1989;85:2608–22.CrossRefPubMed
30.
Forrest K, Weismer G. Dynamic aspects of lower lip movement in Parkinsonian and neurolgically normal geriatric speakers’ production of stress. J Speech Hear Res. 1995;38:260–72.CrossRefPubMed
31.
Ramig L, Fox C, Sapir S. Parkinson’s disease: speech and voice disorders and their treatment with the lee Silverman voice treatment. Semin Speech Lang. 2004;25:169–80.CrossRefPubMed
32.
Huh YE, Park J, Suh MK, Lee SE, Kim J, Jeong Y, Kim HT, Cho JW. Differences in early speech patterns between Parkinson variant of multiple system atrophy and Parkinson’s disease. Brain Lang. 2015;147:14–20.CrossRefPubMed
33.
Skodda S, Visser W, Schlegel U. Gender-related patterns of dysprosody in parkinson disease and correlation between speech variables and motor symptoms. J Voice. 2011;25:76–82.CrossRefPubMed
34.
Stelzig Y, Hochhaus W, Gall V, Henneberg A. Laryngeal findings of patients with Parkinson’s disease. Ann Otol Rinol Laryngol. 2004;113:253–8.CrossRef
35.
Holmes RJ, Oates JM, Phyland DJ, Hughes AJ. Voice characteristics in the progression of Parkinson’s disease. Int J Lang Commun Disord. 2000;35:407–18.CrossRefPubMed
36.
Lee JJ, Ham JH, Lee PH, Sohn YH. Gender differences in age-related Striatal dopamine depletion in Parkinson’s disease. J Mov Disord. 2015;8(3):130–5.CrossRefPubMedPubMedCentral
37.
Smith KM, Dahodwala N. Sex differences in Parkinson’s disease and other movement disorders. Exp Neurol. 2014;259:44–56.CrossRefPubMed
38.
Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J. Are men at greater risk for Parkinson’s disease than women? J Neurol Neurosurg Psychiatry. 2004;75:637–9.CrossRefPubMedPubMedCentral
39.
Bourque M, Dluzen DE, Di Paolo T. Neuroprotective actions of sex steroids in Parkinson’s disease. Front Neuroendocrinol. 2009;30:142–57.CrossRefPubMed
40.
Al-Sweidi S, Morissette M, Bourque M, Di Paolo T. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson’s disease. Neuropharmacology. 2011;61:583–91.CrossRefPubMed
41.
Tsang KL, Ho SL, Lo SK. Estrogen improves motor disability in parkinsonian postmenopausal women with motor fluctuations. Neurology. 2000;54:2292–8.CrossRefPubMed
42.
Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF. Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol. 2004;61:886–8.CrossRefPubMed
43.
Saunders-Pullman R. Estrogens and Parkinson disease: neuroprotective, symptomatic, neither, or both? Endocrine. 2003;21(1):81–7.CrossRefPubMed
44.
Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R. Familial and environmental risk factors in Parkinson’s disease: a case-control study in north-east Italy. Acta Neurol Scand. 2002;105:77–82.CrossRefPubMed
45.
Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT Jr, Checkoway H. Pesticides and risk of Parkinson disease: a population-based case-control study. Arch Neurol. 2005;62:91–5.CrossRefPubMed
46.
McNaught KS, Perl DP, Brownell AL, Olanow CW. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson’s disease. Ann Neurol. 2004;56:149–62.CrossRefPubMed
47.
Gorell JM, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Brown GG, et al. Occupational exposures to metals as risk factors for Parkinson’s disease. Neurology. 1997;48:650–8.CrossRefPubMed
48.
Mshana G, Dotchin CL, Walker RW. ‘We call it the shaking illness’: perceptions and experiences of Parkinson’s disease in rural northern Tanzania. BMC Public Health. 2011;11:219. doi: 10.​1186/​1471-2458-11-219.
49.
Klepac N, Pikija S, Kraljić T, et al. Association of rural life setting and poorer quality of life in Parkinson's disease patients: a cross-sectional study in Croatia. Eur J Neurol. 2007;14(2):194–8.CrossRefPubMed
Metadata
Title
The analysis of relationship between selected sociodemografic factors and disorders of speech organs in Parkinson`s patients
Authors
Wioletta Pawlukowska
Karolina Skonieczna-Żydecka
Iwona Rotter
Krystyna Honczarenko
Przemysław Nowacki
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2017
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-1003-2

Other articles of this Issue 1/2017

BMC Neurology 1/2017 Go to the issue

Research article

Clinical and electrophysiological features of post-traumatic Guillain-Barré syndrome

Research article

Hyperbaric oxygen treatment of spinal cord injury in rat model

Research article

The Turkish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery

Study protocol

The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial

Case report

Case report: a novel frameshift mutation in the mitochondrial cytochrome c oxidase II gene causing mitochondrial disorder

Case report

A case report of thoracolumbar paraspinal myopathy as the cause of camptocormia in a patient with atypical parkinsonism